{"title":"Retraction notice to \"Rabies presenting as acute psychiatric behavioral abnormality with delayed onset after dog bite: A fatal case report\" [Diagnostic Microbiology & Infectious Disease 113 (2025) 116881].","authors":"Lan Mou, Hong Wang, Jianhua Li, Shikai Wang","doi":"10.1016/j.diagmicrobio.2026.117627","DOIUrl":"10.1016/j.diagmicrobio.2026.117627","url":null,"abstract":"","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":" ","pages":"117627"},"PeriodicalIF":1.8,"publicationDate":"2027-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hewei Zhang, Yin Wang, Elizabeth Porter, Nanyan Lu, Yanhua Li, Fangfeng Yuan, Molly Lohman, Lance Noll, Wanglong Zheng, Colin Stoy, Yuekun Lang, Victor C Huber, Wenjun Ma, Lalitha Peddireddi, Ying Fang, Jishu Shi, Gary Anderson, Xuming Liu, Jianfa Bai
{"title":"Corrigendum to \"Development of a multiplex real-time RT-PCR assay for simultaneous detection and differentiation of influenza A, B, C, and D viruses\" [Diagnostic Microbiology and Infectious Disease 95 (2019) 59-66].","authors":"Hewei Zhang, Yin Wang, Elizabeth Porter, Nanyan Lu, Yanhua Li, Fangfeng Yuan, Molly Lohman, Lance Noll, Wanglong Zheng, Colin Stoy, Yuekun Lang, Victor C Huber, Wenjun Ma, Lalitha Peddireddi, Ying Fang, Jishu Shi, Gary Anderson, Xuming Liu, Jianfa Bai","doi":"10.1016/j.diagmicrobio.2026.117622","DOIUrl":"10.1016/j.diagmicrobio.2026.117622","url":null,"abstract":"","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":" ","pages":"117622"},"PeriodicalIF":1.8,"publicationDate":"2027-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148886721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hepatitis C care cascade in a university hospital: Gaps in HCV RNA testing and treatment initiation.","authors":"Güliz Uyar Güleç, Sevin Kırdar","doi":"10.1016/j.diagmicrobio.2026.117749","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117749","url":null,"abstract":"<p><strong>Background: </strong>Evaluation of the hepatitis C virus (HCV) care cascade using real-world data helps identify gaps in HCV elimination strategies. This study assessed the HCV care cascade in a tertiary-care university hospital in Türkiye and investigated factors associated with confirmatory HCV RNA testing.</p><p><strong>Methods: </strong>All individuals who underwent anti-HCV testing between 2017 and 2020 were retrospectively evaluated, without age restrictions. The cascade stages included anti-HCV positivity, confirmatory HCV RNA testing, antiviral treatment initiation, and post-treatment virological assessment. Multivariable logistic regression was used to identify factors associated with confirmatory HCV RNA testing.</p><p><strong>Results: </strong>Among 95,836 individuals tested, 690 (0.72%) were anti-HCV positive. Confirmatory HCV RNA testing was performed in 505 (73.2%), of whom 151 (29.9%) had detectable HCV RNA. Treatment was initiated in 96 (63.6%) of the 151 viremic patients. Post-treatment HCV RNA results were available for 78 of the 96 treated patients; 18 had no documented post-treatment assessment. In multivariable analysis, evaluation in internal medicine departments (adjusted odds ratio [aOR], 5.62; 95% CI, 3.77-8.37; P < 0.001) and higher anti-HCV signal-to-cutoff levels (aOR, 1.08; 95% CI, 1.04-1.13; P < 0.001) were independently associated with confirmatory testing.</p><p><strong>Conclusion: </strong>Confirmatory HCV RNA testing was the major point of attrition in the care cascade, with substantial differences between internal medicine and surgical departments. Additional gaps occurred in treatment initiation and post-treatment assessment. Reflex testing and electronic alerts may warrant evaluation as potential strategies to improve continuity of care.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117749"},"PeriodicalIF":1.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aranya Kumar Das, Kiran Bala, Manish Soneja, Deepti Vibha, Vivek Shankar, Prayas Sethi, Maroof Ahmad Khan, Urvashi B Singh
{"title":"Diagnostic utility of lipoarabinomannan antigen detection in urine for the diagnosis of spinal tuberculosis in HIV negative population.","authors":"Aranya Kumar Das, Kiran Bala, Manish Soneja, Deepti Vibha, Vivek Shankar, Prayas Sethi, Maroof Ahmad Khan, Urvashi B Singh","doi":"10.1016/j.diagmicrobio.2026.117750","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117750","url":null,"abstract":"<p><strong>Background: </strong>Microbiological confirmation of spinal tuberculosis (TB) is challenging because of paucibacillary nature and difficulty obtaining tissue samples. Evidence regarding urinary lipoarabinomannan (LAM) in spinal TB, among HIV-negative patients, is limited. We evaluated its diagnostic performance in spinal TB.</p><p><strong>Methods: </strong>We conducted a prospective observational diagnostic accuracy study at a tertiary-care centre in New Delhi, India, between September 2024 and June 2026. Adults (>18 years) with suspicion of spinal TB who were antitubercular treatment-naïve or had treatment for <2 weeks were enrolled. Urinary LAM testing was performed using Abbott Determine™ TB LAM assay. Diagnostic performance was assessed against microbiological and composite reference standards.</p><p><strong>Results: </strong>We enrolled 139 participants, including 71 (51.1%) with isolated Pott's spine and 68 (48.9%) with disseminated TB involving spine. Microbiological sampling was possible in 122 (87.8%), with 89 (64.0%) confirmed TB cases. Urinary LAM was positive in 44/139 (31.7%). Against disease status defined as concordant microbiological and composite reference standards, urinary LAM showed 92.3% specificity and 37.3% sensitivity, with a PPV of 95.7% and NPV of 24.5%. Specificity and PPV were 100% in isolated Pott's spine and 87.5% in disseminated TB involving spine. Against MGIT, sensitivity was 34.2% and specificity 69.6%. Combining urinary LAM with GeneXpert increased sensitivity to 100% against MGIT.</p><p><strong>Conclusion: </strong>Urinary LAM demonstrated high specificity, good rule-in potential in HIV-negative spinal tuberculosis. A positive result provides useful supportive evidence, particularly when microbiological confirmation is difficult. As a non-invasive test, it may complement GeneXpert as an adjunctive diagnostic tool, especially in resource-limited settings.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117750"},"PeriodicalIF":1.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Combinatorial effect of STK11 with rifampicin prevents the growth of Mycobacterium tuberculosis bacilli more effectively through the M2 to M1 repolarization in J774A.1 macrophage.","authors":"Arijeet Samanta, Madhusri Pramanik, Nayanika Datta, Sajal Dasmahapatra, Santanu Kar Mahapatra","doi":"10.1016/j.diagmicrobio.2026.117748","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117748","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis remains a major global health challenge, disproportionately affecting developing countries-most notably in India, which accounts for the largest number of cases worldwide. This study aimed to explore the efficacy of Cocos nucifera L. derived glycoprotein STK11 in combination with rifampicin to investigate the significance of host-directed therapy against Mycobacterium tuberculosis infected macrophages.</p><p><strong>Methods: </strong>The therapeutic worth of the STK11 and rifampicin in combination was evaluated against M. tuberculosis H37Ra bacilli using a resazurin microplate assay to measure extracellular growth. Additionally, an intracellular survival assay was performed to determine bacillary restriction within infected macrophages. Macrophage polarization profiles (M1 vs. M2 markers) were evaluated via RT-PCR and ELISA, and arginase activity was monitored to assess functional biochemical shifts.</p><p><strong>Results: </strong>The combination of STK11 and rifampicin restricted H37Ra bacilli growth by up to 63.19% more effectively than individual treatments. Furthermore, this combination restricted intracellular bacillary growth within macrophages by up to 72.20% compared to single-drug treatments. During baseline H37Ra macrophage infection, RT-PCR revealed an upregulation of M2 markers (Arg1, YM-1, FIZZ1, CD206, IL-4, IL-10) and a downregulation of M1 markers (iNOS2, CD40, CD68, IL-6, IL-12). However, combination therapy with STK11 and rifampicin significantly (p<0.05) decreased arginase activity and restored M1 marker expression. These results demonstrated the shift of M2 macrophage polarization to M1 phenotype which might crucial for restricting M. tuberculosis growth.</p><p><strong>Conclusions: </strong>Altogether, this study claimed that the C. nucifera L. derived glycoprotein STK11 provided a viable host-directed combination therapy with rifampicin to enhance clearance and effective suppression of M. tuberculosis H37Ra growth.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117748"},"PeriodicalIF":1.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.","authors":"Jianwei Zhang, Jinlong Ding, Xinqi Ma","doi":"10.1016/j.diagmicrobio.2026.117747","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117747","url":null,"abstract":"<p><strong>Objective: </strong>Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.</p><p><strong>Methods: </strong>This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.</p><p><strong>Results: </strong>HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).</p><p><strong>Conclusions: </strong>HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.</p><p><strong>Importance: </strong>The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117747"},"PeriodicalIF":1.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Merve Ertürk Melez, Pınar Sağıroğlu, Sıtkı Özgür Altop, Mustafa Altay Atalay, Orhan Yıldız
{"title":"Comparison of MALDI-TOF MS and VITEK 2 performance in the identification of brucella strains isolated from blood culture bottles; retrospective evaluation of antibiotic resistance profiles, clinical manifestations, and serological follow-up.","authors":"Merve Ertürk Melez, Pınar Sağıroğlu, Sıtkı Özgür Altop, Mustafa Altay Atalay, Orhan Yıldız","doi":"10.1016/j.diagmicrobio.2026.117744","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117744","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Brucella species cause severe zoonotic infections with an exceptionally high risk of laboratory-acquired transmission. We systematically evaluated and compared the identification performances of two contemporary MALDI-TOF MS platforms and the VITEK 2 automated system, analyzed serial standard tube agglutination (STA) titer kinetics, and determined in vitro antimicrobial susceptibility profiles of clinical blood culture isolates.</p><p><strong>Materials and methods: </strong>Twenty-five culture-confirmed Brucella isolates recovered from peripheral blood culture bottles between 2019 and 2025 were evaluated using the MALDI Biotyper Sirius (routine MBT Compass library), VITEK MS Prime (IVD database v3.3), and VITEK 2 GN automated identification cards. All sample manipulation and ethanol/formic acid extraction were performed inside a certified Class II Biosafety Cabinet ensuring complete inactivation prior to mass spectrometry. Antimicrobial susceptibility was determined by the disk diffusion method on Mueller-Hinton Fastidious (MH-F) agar according to EUCAST (v. 16.0) guidelines. Clinical data and serial STA titers were retrospectively analyzed.</p><p><strong>Results: </strong>The MALDI Biotyper Sirius accurately identified all 25 isolates (100%) at the species level as Brucella melitensis, whereas the VITEK MS Prime identified all (100%) at the genus level (Brucella spp.). In contrast, the VITEK 2 GN automated system demonstrated markedly poor diagnostic utility, correctly identifying 92% (23/25) of isolates, failing to identify one isolate ('unidentified'), and misidentifying another blood culture isolate as Roseomonas gilardii. A statistically significant decrease in Wright tube agglutination titers was observed following treatment (median initial titer 1:320 [IQR, 1:160-1:640] vs. median final titer 1:80 [IQR, 1:40-1:160]; p = 0.007). Serological reductions did not differ significantly across therapeutic regimens (p = 0.3219). All isolates (100%) were fully susceptible to rifampin, doxycycline and gentamicin. Resistance rates to trimethoprim-sulfamethoxazole (SXT) and ciprofloxacin were 40% (10/25) and 24% (6/25), respectively. Favorable clinical cure without relapse was achieved in patients receiving SXT-containing regimens despite in vitro resistance.</p><p><strong>Conclusions: </strong>The MALDI Biotyper Sirius provides superior diagnostic speed and biosafety via reliable species-level identification using routine spectral libraries. Automated phenotypic misidentifications (e.g., R. gilardii) represent critical biohazards that warrant urgent MALDI-TOF MS verification. High in vitro resistance to SXT highlights potential disk diffusion overestimation in fastidious organisms, emphasizing the necessity of broth microdilution MIC confirmation before precluding vital oral treatment options.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117744"},"PeriodicalIF":1.8,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnostic significance of low-level Mycobacterium tuberculosis detection by the BD MAX MDR-TB assay: A retrospective descriptive study.","authors":"Oğuz Alp Gürbüz, Zübeyde Lale, Nesibe Nur Aydın","doi":"10.1016/j.diagmicrobio.2026.117740","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117740","url":null,"abstract":"<p><strong>Background: </strong>Nucleic acid amplification tests (NAATs) are crucial for the quick diagnosis of tuberculosis (TB). Low-positive BD MAX MDR-TB PCR results continue to be diagnostically difficult, and clinical outcomes for this patient group have not been thoroughly characterised.</p><p><strong>Objective: </strong>To evaluate the clinical significance of low-positive BD MAX MDR-TB PCR results and determine the proportion of patients subsequently diagnosed with TB or with a prior TB history.</p><p><strong>Methods: </strong>This retrospective descriptive study included patients tested with BD MAX MDR-TB PCR between January 2023 and December 2025. Among 16,134 tested samples, 70 patients with low-positive results were identified. Concurrent microbiological data, including acid-fast bacilli smear microscopy, MGIT culture, Löwenstein-Jensen culture, and antibiogram results when available, were reviewed.</p><p><strong>Results: </strong>Persistent low-positivity was observed in 47 (67.1%) of 70 patients on repeat testing, of whom 28 (59.6%) were diagnosed with TB or had prior TB treatment. The remaining 23 patients (32.9%) converted to negative on repeat testing; all had negative smear and culture results, and no active TB diagnosis was established.</p><p><strong>Conclusions: </strong>Low-positive results provides an early molecular signal that can trigger timely clinical assessment, infection-control measures, and targeted microbiological follow-up before definitive culture results become available but when clinical suspicion is low and subsequent AFB smear and culture results are negative, a low-positive molecular result should be interpreted cautiously and should not, by itself, establish a diagnosis of active TB.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117740"},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jonas Steenholdt Sparvath, Randi Føns Petersen, Jørgen Skov Jensen, Charlotte Kjelsø, Søren Anker Uldum
{"title":"Genus-wide PCR and 23S-5S ISR sequencing reveals diverse non-pneumophila Legionella in clinical respiratory samples.","authors":"Jonas Steenholdt Sparvath, Randi Føns Petersen, Jørgen Skov Jensen, Charlotte Kjelsø, Søren Anker Uldum","doi":"10.1016/j.diagmicrobio.2026.117738","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117738","url":null,"abstract":"<p><strong>Objectives: </strong>To determine how the breadth of the molecular diagnostic target shapes detection of Legionella in clinical respiratory samples, and to characterise the species diversity of non-pneumophila Legionella (non-Lp) using 23S-5S rRNA intergenic spacer region (ISR) sequencing.</p><p><strong>Methods: </strong>Respiratory samples reported Legionella PCR-positive by Danish laboratories during 2023-2024 were reconfirmed at the national reference laboratory by real-time PCR targeting 16S rRNA (genus), mip (L. pneumophila) and wzm (serogroup 1). Samples positive for 16S rRNA but negative for mip underwent 23S-5S ISR sequencing with phylogenetic and UPGMA-based species assignment. Detection patterns were compared between hospitals using genus-wide versus L. pneumophila-specific assays. Culture confirmation was modelled against Ct value by species and specimen type.</p><p><strong>Results: </strong>Among 509 PCR-positive patients, genus-level 16S rRNA testing reconfirmed Legionella in clinically indicated samples that L. pneumophila-specific assays would have reported negative. Of 96 high-quality ISR sequences, non-Lp detections were distributed broadly across the Legionella phylogeny, including L. longbeachae, L. bozemanae, L. anisa, several rare species and unassigned clusters. A subset of mip-negative samples was genuinely L. pneumophila, showing that even same-species narrow detection can fail. Culture confirmation was higher for L. pneumophila (50%) than for non-Lp species (0-47%). Among 420 notified Legionnaires' disease cases, 85 (20.2%) were non-Lp.</p><p><strong>Conclusions: </strong>A negative L. pneumophila PCR does not exclude legionellosis. Genus-wide molecular detection recovers confirmed infections missed by narrow assays, and the wide phylogenetic spread of organisms means a broad approach, not a small species-specific add-on, is required for adequate diagnosis and surveillance.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117738"},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}